Predictive value of ultrasound-guided detection of FNA-Tg and FNA-TgAb in cervical lymph node metastasis of papillary thyroid carcinoma

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100050194

Enrollment

Unknown

Registered

2021-08-22

Start date

2020-01-01

Completion date

Unknown

Last updated

2022-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

papillary thyroid carcinoma

Interventions

Gold Standard:Pathological diagnosis

Index test:FNA-Tg

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patients who were pathologically diagnosed with PTC who underwent thyroid cancer surgery and lateral cervical LN dissection in Panzhihua Central Hospital and the patients who underwent thyroid cancer surgery in other hospitals and then underwent lateral cervical LN dissection in our hospital were enrolled. All enrolled patients signed the informed consent for the study.

Exclusion criteria

Exclusion criteria: 1) postoperative pathology showed heterogeneous tumor comprising PTC with follicular carcinoma, poorly differentiated carcinoma, medullary carcinoma, undifferentiated carcinoma, etc.; 2) history of cervical LN tuberculosis or other cervical tumors; 3) coagulation dysfunction; 4) history of radiotherapy, chemotherapy, 131I ablation, and other tumor-related treatments before surgery.

Design outcomes

Primary

Measure	Time frame
LN-FNA-Tg and LN-FNA-TgAb;	—

Countries

China

Contacts

Public ContactWu Xiaoli

Panzhihua Municipal Central Hospital

wxl13982323405@126.com+86 13982323405

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026